Khuroo MS. Viral hepatitis in international travellers: risks and prevention. Int J Antimicrob Agents 2003; 21(2):143−152.
Dagan R. Szczepienia. JAMA 2005; 294: 202–210 (Oprac. Med Prakt Pediatria Supl. 2/2007: 25–26).
Steffen R. Hepatitis A and B: risks compared with other vaccine-preventable diseases and immunization recommendations.Vaccine 1993; 11, 518–520.
Steffen R. Hepatitis A in travelers: the European experience. J Infect Dis 1995; 171(Suppl. 1): 24−28.
Szczepienia ochronne w Polsce w 2005 roku. Warszawa: Państwowy Zakład Higieny; 2006.
Hollinger FB, Ticehurst JR. Hepatitis A virus. In. Fields virology. 3 ed. Philadelphia: Lippincott-Raven; 1996: 735–782.
Program Szczepień Ochronnych na rok 2010.
Lee SD, Chan CY, Yu MI, et al. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters. Am J Gastroenterol 1996; 91(7): 1360–1362.
Andre F, Van Damme P, Safary A, Banatvala J. Miscellaneous. Inactivated hepatitis A vaccine: immunogenicity, efficacy,safety and review of official recommendations for use. Expert Rev Vaccines 2002; 1(1): 9−23.
Clemens R, Safary A, Hepburn A, et al. Clinical experience with an inactivated hepatitis A vaccine. J Infect Dis 1995; 171(Suppl. 1): 44–49.
Connor BA, VanHerck K, Van Damme P. Rapid protection and vaccination against hepatitis A for travelers. BioDrugs 2003; 17(Suppl. 1): 19−21.
Victor JC, Monto AS, Surdina TY, et al. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. NEJM 2007; 357: 1685–1694 (Oprac. pol. Med. Prakt. Pediatria, Supl. 2/2007): 42–44
CDC. Update: prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR CDC Surveill Summ 2007; 56(41): 1080–1084.
Lok ASF, McMahon B. AASLD practice guidelines chronic hepatitis B: Update 2009. Hepatology 2009; 50(3): 1−36.